Endocrine-Related Cancer

Papers
(The H4-Index of Endocrine-Related Cancer is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
PRRT in high-grade gastroenteropancreatic neuroendocrine neoplasms (WHO G3)74
COVID-19 and androgen-targeted therapy for prostate cancer patients59
The molecular characteristics of high-grade gastroenteropancreatic neuroendocrine neoplasms58
Redifferentiation of radioiodine-refractory thyroid cancers50
Thyroid dysfunction and cancer incidence: a systematic review and meta-analysis47
Spartalizumab in metastatic, well/poorly differentiated neuroendocrine neoplasms47
Androgen hazards with COVID-1945
Innovative imaging of insulinoma: the end of sampling? A review42
Neuroendocrine neoplasm update: toward universal nomenclature42
The tumor microenvironment and immune responses in prostate cancer patients34
Molecular profiling for acromegaly treatment: a validation study33
The 2022 WHO classification of thyroid tumors: novel concepts in nomenclature and grading33
Therapy considerations in neuroendocrine prostate cancer: what next?32
Squamous cell carcinoma of thyroid: a unique type of cancer in World Health Organization Classification32
Prognostic factors for the outcome of nonfunctioning pancreatic neuroendocrine tumors in MEN1: a systematic review of literature32
The role of vitamin D in breast cancer risk and progression30
Duality of glucocorticoid action in cancer: tumor-suppressor or oncogene?30
HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: Metastatic pheochromocytomas and paragangliomas: proceedings of the MEN2019 workshop29
Thyroid cancer in the age of COVID-1929
HIF2α supports pro-metastatic behavior in pheochromocytomas/paragangliomas29
Redifferentiation-facilitated radioiodine therapy in thyroid cancer28
Immune checkpoint inhibitor related hypophysitis: diagnostic criteria and recovery patterns28
Obese adipose tissue extracellular vesicles raise breast cancer cell malignancy27
The natural history and treatment of non-functioning pituitary adenomas (non-functioning PitNETs)26
The role of delta-like non-canonical Notch ligand 1 (DLK1) in cancer25
0.05703592300415